The global mammography market was valued at USD 13.86 billion in 2025 and is projected to grow from USD 14.31 billion in 2026 to USD 19.37 billion by 2034, registering a compound annual growth rate (CAGR) of 3.9% during the forecast period. North America dominated the market with a 73.09% share in 2025.
Mammography is a medical imaging technique used to detect, diagnose, and monitor breast abnormalities, particularly breast cancer. It plays a critical role in early detection and preventive healthcare by identifying suspicious changes in breast tissue. Growing breast cancer incidence, increased awareness of screening, and expanding diagnostic infrastructure are supporting demand for mammography services worldwide.
Key Market Trends
A major trend in the mammography market is the growing adoption of artificial intelligence (AI)-enabled three-dimensional digital breast tomosynthesis (DBT). Unlike conventional two-dimensional imaging, DBT captures images from multiple angles to provide a more detailed view of breast tissue. This approach can improve abnormality detection, particularly in women with dense breasts.
AI integration is also improving mammography workflows by helping radiologists identify suspicious lesions, prioritize cases, and reduce image interpretation time. In April 2026, GE HealthCare expanded its collaboration with RadNet's DeepHealth to commercialize AI-powered mammography solutions globally. Such partnerships highlight the industry's focus on improving screening efficiency and diagnostic accuracy.
Another emerging trend is personalized breast cancer screening. Healthcare providers are increasingly considering breast density, family history, genetic predisposition, and individual risk factors when selecting screening approaches.
Market Growth Drivers
The increasing implementation of breast cancer screening programs is a primary driver of market growth. Governments, healthcare organizations, and cancer societies promote routine screening to support early detection and improve treatment outcomes. Public awareness campaigns and improved access to diagnostic facilities are encouraging more women to undergo mammography examinations.
The rising incidence of breast cancer is further strengthening demand. Mammography helps identify abnormalities before symptoms become apparent, allowing healthcare professionals to investigate suspicious findings and determine appropriate treatment.
Technological advancements are also supporting adoption. Digital mammography, DBT, contrast-enhanced mammography, and AI-assisted interpretation are improving imaging capabilities and workflow efficiency. Healthcare facilities are investing in modern systems to enhance diagnostic services and manage increasing examination volumes.
Additionally, the expansion of specialized breast imaging centers and preventive healthcare initiatives is creating opportunities for equipment providers and diagnostic service companies.
Market Segmentation
The mammography market is segmented by service, imaging modality, and end user.
By service, the market includes screening mammography services, diagnostic mammography services, and mammography-guided interventional services. Screening mammography held the leading position in 2025, supported by routine examinations, preventive healthcare initiatives, and organized screening programs. Mammography-guided interventional services are projected to grow at a CAGR of 5.9%, driven by demand for image-guided procedures.
By imaging modality, the market includes 2D digital mammography services, 3D digital breast tomosynthesis services, contrast-enhanced mammography services, and others. 3D digital breast tomosynthesis accounted for 50.6% of the market in 2025 because it provides detailed breast tissue visualization and reduces tissue overlap. Contrast-enhanced mammography is projected to grow at a CAGR of 5.3%.
By end user, the market includes hospitals, specialty clinics, diagnostic centers, and others. Hospitals held the largest share in 2025 because they provide integrated screening, diagnostic imaging, biopsy, and cancer treatment services. The segment is expected to account for 43.9% of the market in 2026. Specialty clinics are projected to grow at a CAGR of 4.5%, supported by demand for dedicated breast healthcare services.
Regional Analysis
North America dominated the market, generating USD 10.13 billion in 2025. Advanced healthcare infrastructure, favorable reimbursement systems, and widespread adoption of modern breast imaging technologies support regional leadership. The U.S. market is projected to reach USD 10.11 billion in 2026.
Europe is projected to reach USD 2.13 billion in 2026, registering a CAGR of 3.9%. Established screening programs, government support, and advanced diagnostic infrastructure support demand. Germany's market is expected to reach USD 0.40 billion, while the U.K. market is projected to reach USD 0.24 billion in 2026.
Asia Pacific is expected to reach USD 1.18 billion in 2026, becoming the third-largest regional market. Rising breast cancer incidence, improving healthcare infrastructure, and growing awareness of early detection are supporting adoption. China's market is projected to reach USD 0.51 billion, Japan USD 0.33 billion, and India USD 0.08 billion in 2026.
Latin America and the Middle East and Africa are expected to experience moderate growth as diagnostic infrastructure and access to screening services improve. Latin America's market is projected to reach USD 0.34 billion in 2026. 6. Market Challengesficant challenges. Advanced DBT systems, contrast-enhanced imaging platforms, and AI-
enabled software require substantial investment, limiting adoption among smaller healthcare facilities and rural diagnostic centers.
Shortages of trained breast radiologists and imaging technologists can also affect service availability and reporting times. In developing markets, limited reimbursement and healthcare funding may reduce screening coverage. Addressing these challenges requires workforce training, affordable technologies, and improved access to diagnostic facilities.
Competitive Landscape
The mammography market includes diagnostic imaging providers and healthcare service companies. Key players identified by Fortune Business Insights include RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., Fortis Healthcare Ltd., Affidea Group, Unilabs, Evidia Group, and I-MED Radiology Network.
Companies are focusing on advanced imaging technologies, AI integration, strategic collaborations, and expanded screening programs. Investments in diagnostic capacity, workflow optimization, and improved patient access remain important competitive strategies.
Market Outlook
The mammography market is expected to grow steadily through 2034 as breast cancer screening programs expand and healthcare providers adopt advanced imaging technologies. AI-assisted interpretation, 3D breast tomosynthesis, and personalized screening strategies will create further opportunities.
Future growth will depend on improving affordability, expanding access to screening, addressing workforce shortages, and strengthening diagnostic infrastructure. Companies that combine reliable imaging services with advanced technologies and accessible screening programs are likely to benefit from the market's continued development.
Comments